• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of highest risk domestic inspections in the quarter resulting in a category of classifications called OTHER

Dictionary: The number of inspections where one of the following four outcomes occurred. 1. Referred to State for Follow-Up: the findings of the inspection were such that there is no federal jurisdiction over the apparent violation in question or it is determined that State action is the most efficient method of obtaining the establishment’s compliance with Federal laws, regulations or administrative requirements. 2. Referred to Center: the Establishment Inspection Report has been referred to the appropriate Center for a final inspection district decision. 3. Not Yet Completed by Investigator: the inspection has been completed but the investigator has not yet reported [into the database] what district decision will be recommended. 4. Not Yet Endorsed by Investigations: the investigator’s recommendation regarding the district decision has not yet been endorsed (reviewed and approved) by the investigator’s supervisor.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber Classified as Other
Oct 2011N/A10
Nov 2011N/A9
Dec 2011N/A12
Jan 2012N/A9
Feb 2012N/A11
Mar 2012N/A11
Apr 2012N/A8
May 2012N/A10
Jun 2012N/A13
Jul 2012N/A7
Aug 2012N/A11
Sep 2012N/A16

FY 2012 Total: 127

Percent of highest risk domestic inspections in the quarter resulting in a classification of Other

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetPercent Classified as Other
Oct 2011N/A1
Nov 2011N/A1
Dec 2011N/A1
Jan 2012N/A1
Feb 2012N/A1
Mar 2012N/A1
Apr 2012N/A1
May 2012N/A1
Jun 2012N/A1
Jul 2012N/A1
Aug 2012N/A1
Sep 2012N/A2


Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.